| Location | Isolates | Organism | Resistance rate (%) |
|---|---|---|---|
| Sikkim (2011) | 291 clinical Ssecimens, 196 carrier screening nasal samples | Methicillin-Resistant Staphylococcus aureus (MRSA) | 38.14 in clinical specimens, 20.92 in nasal samples |
| Tertiary trauma Center of AIIMS, New Delhi (2011) |
3,984 clinical specimens |
Gram-negative Pseudomonas, Acinetobactor, Klebsiella, E.coli, Enterobacter sp., Gram-positive S. aureus, Coagulase negative staphylococci |
Overall resistance of gram-negative organisms was 50 against carbapenems, 66 aminoglycosides, 76 Fluoroquinolones, 88 third generation cephalosporins |
| CMC Vellore, various centers across India (2010) | 176 clinical specimens |
P. aeruginosa | Among the 61 P. aeruginosa isolates, resistance to carbapenem was 42.6. |
| Puducherry (2010) | 31 clinical samples | K. pneumoniae | 93.55 multiple drug resistant and ESBL producer |
| Mangalore (2010) | 83 Community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) clinical isolates | CA-MRS strains | 92.8 were resistant to penicillin, 31.32 to erythromycin |
| Lok Nayak Hospital, New Delhi (2010) | 83 isolates from OPD cases of pyoderma |
CA-MRSA | 9.6 |
| Mangalore (2010) | 180 clinical samples | Enterococcal strains | 16.67 to 42.86 to aminoglycosides |
| Nagpur (2009) | 1300 nasopharyngeal swabs from school children | MRSA | 4.16 |
| Puducherry (2008) | 261 clinical isolates | 72.34 of Staphylococcus aureus resistant to oxacillin | |
| Lucknow (2007) | 2995 blood samples |
Klebsiella spp., Staphylococcus isolates | Extended-spectrum beta-lactamases (ESBL) producing Klebsiella spp. were 98.28 resistant to ampicillin, ticarcillin and piperacillin. Monobactam and cephalosporin resistance was also higher (>60) |
| Kolkata (2007) | 284 clinical isolates | Metallo-beta-lactamase (MBL) producing bacteria | 43.3 were resistant to at least seven antibiotics (ampicillin, amoxicillin, cephalexin, ciprofloxacin, cotrimaxazole, erythromycin,gentamycin) |
| MVIDH, Delhi (2007) | 9858 stool samples | V. cholera | 96 to furazolidone, cotrimoxazole and nalidixic acid |